1R(a)kel A,Sheehy O,Rahme E,et al.Osteoporosis among patients with type 1 and type 2 diabetes[J].Diabetes Metab,2008,34(3):193.
2Turko IV,Marcondes S,Murad F.Diabetes-associated nitration of tyrosine and inactivation of succinyl-CoA:3-oxoacidCoA-transferase[J].AmJ Physiol Heart Circ Physiol,2001,281(6):H2289.
4Evans JL,Goldfine ID,Maddux BA,et al.Oxidative stress and stress-activated signaling pathways:a unifying hypothesis of type 2 diabetes[J].Endocr Rev,2002,23(5):599.
5Evans JL,Goldfine ID,Maddux BA,et al.Oxidative stress and stress-activated signaling pathways:a unifying hypothesis of type2 diabetes[J].Endocr Rev,2002,23(5):599.
6Valko M,Leibfritz D,Moncol J,et al.Free radicals and antioxidants in normal physiological functions and human disease[J].Int J Biochem Cell Biol,2007,39(1):44.
7Nishikawa T,Edelstein D,Du XL,et al.Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage[J].Nature,2000,404(6779):787.
3Satoh M, Fujimoto S, Haruna Y, et al. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am J Physiol Renal Physiol, 2005,288 (6): F1144-F1152.
4Tojo A, Asaba K, Onozato ML. Suppressing renal NADPH oxidase to treat diabetic nephropathy. Expert Opin Tber Targets,2007,11 (8) :1011-1018.
5Yoo CW, Song CY, Kim BC, et al. Glycated albumin induces superoxide generation in mesangial cells. Cell Physiol Biochem, 2004, 14 (426):361-368.
6Lee HB, Yu MR, Yang Y, et al. Reactive oxygen species - regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol, 2003, 14 (8 Suppl 3) :S241-S245.
7Kitada M, Koya D, Sugimoto T, et al. Translocation of glomerular P47phox and p67phox by protein kinase C-β activation is required for oxidative stress in diabetic nephropathy. Diabetes, 2003, 52 (10):2603-2614.
8Gojo A, Utsunomiya K, Taniguchi K, et al. The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats. Eur J Pharmacol, 2007,568 ( 1-3 ) : 242-247.
9Ogawa S, Mori T, Nako K, et al. Angiotensin Ⅱ type 1 receptor blockers reduce urinary oxidative stress markers in hypertensive diabetic nephropathy. Hypertension, 2006, 47 (4) :699-705.
10Chade AR, Rodriguez-Porcel M, Herrmann J, et al. Beneficial effects of antioxidant vitamins on the stenotic kidney. Hypertension,2003,42(4) :605-612.
